Agenu Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Eric olsonCompensation committee of agenu board directorsAgenus incCompensation committeeAgenu boardEquity planNasdaq listing ruleGrant date

Agenus Announces Reverse Stock Split of Common Stock

Agenus Inc. , a leader in discovering and developing novel immunological agents to treat various cancers, today announced its stockholders have approved a one-for-twenty reverse stock split of its.

Exchange commission onAgenus incEquiniti trust companyExchange commissionEastern timeNasdaq capital marketsNasdaq capital marketAgenu boardTrust companyRisk factorsAnnual report

Agenus (AGEN) Announces 1:20 Reverse Stock Split

Agenus (AGEN) Announces 1:20 Reverse Stock Split
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Exchange commission onAgenus incEquiniti trust companyEastern timeNasdaq capital marketsNasdaq capital marketAgenu boardTrust companyExchange commission

Agenus Announces Reverse Stock Split of Common Stock

Agenus Announces Reverse Stock Split of Common Stock
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Exchange agent for the reverse stockExchange commissionAgenus incEquiniti trust companyExchange commission onEastern timeNasdaq capital marketsNasdaq capital marketAgenu boardTrust companyRisk factorsAnnual reportExchange agentReverse stock split

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Agenus Inc. , a leader in discovering and developing novel immunological agents to treat various cancers, today announced that the Compensation Committee of Agenus’ Board of Directors granted, as.

Benny johnsonManuel duenasCompensation committeeAgenus incCompensation committee of agenu board directorsAgenu boardMarket accessSenior medical directorEquity planNasdaq listing ruleGrant date